Johnson & Johnson has filed its bispecific antibody amivantamab to the FDA, hoping to muscle into the big market for drugs that are used to treat EGFR-positive non-small cell lung cancer (NSCLC).
The UK government is launching a £500m Sovereign AI Unit to boost artificial intelligence startups and drive economic growth through strategic and long-term investments Continue Reading ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results